Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Shruti J. Shah
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
Following a five-year investigation into the overseas marketing and sales practices of medical device makers, the DOJ and SEC won’t bring any FCPA enforcement against one of the targeted companies, Zimmer Holdings Inc.
Medical device maker Zimmer Biomet Holdings Inc. agreed Thursday to pay $30.5 million to resolve DOJ and SEC investigations into the company’s “repeat” violations of the Foreign Corrupt Practices Act.
Orthopedic device maker Zimmer Biomet Holdings Inc. said in a securities filing Friday the DOJ and SEC are still investigating possible FCPA violations in Brazil and Mexico.
Medical device maker Zimmer Holdings, Inc. said in an SEC filing yesterday that it can’t predict the outcome of DOJ and SEC investigations into its overseas sales practices.
Zimmer Biomet Holdings Inc. said in a securities filing Monday “it is probable that Biomet will incur additional liabilities related to” DOJ and SEC investigations of FCPA violations that occurred after Biomet’s FCPA settlement in 2012 and during its deferred prosecution agreement.
A former senior vice president at General Cable Corporate settled SEC allegations Thursday that he caused FCPA violations and knowingly circumvented internal accounting controls by approving excessive commission payments to a third-party agent in Angola.
Job Title: Compliance Counsel, Investigations (APAC)
Employer: Zimmer Biomet
Location: Singapore
Job Title: Compliance Counsel, Investigations
Employer: Zimmer Biomet
Location: Washington D.C.
The Securities and Exchange Commission is investigating possible violations of the U.S. Foreign Corrupt Practices Act by Biomet Inc., Stryker Corp., Zimmer Holdings Inc., Smith & Nephew plc and Medtronic Inc. They’ve all made announcements about the SEC’s action and deny any violations. The companies make replacement implants for knees, hips and the spine and […]
The Securities and Exchange Commission awarded more than $4.5 million to a whistleblower whose tip triggered the company to launch an internal investigation and report the whistleblower’s allegations to the SEC and another agency.
